NVST Overview

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Wall Street analysts forecast NVST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is22.22 USD with a low forecast of 18.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Envista Holdings Corp revenue for the last quarter amounts to 750.60M USD, increased 14.96

Envista Holdings Corp. EPS for the last quarter amounts to 0.20 USD, increased 1900.00

Envista Holdings Corp (NVST) has 12000 emplpoyees as of March 11 2026.

Today NVST has the market capitalization of 4.26B USD.